Clinical Trial Update: A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

This clinical trial update reports safety and efficacy data from a Phase 3 study of Golimumab in patients with active rheumatoid arthritis despite methotrexate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED